Clinical Trials Browser

Phase 1/2 × Lovastatin × Clear all

NCT00583102 2018-01-05

Dose Escalation Phase I/II Study of Lovastatin With High-Dose Cytarabine for Refractory or Relapsed AML

Phase 1/2 Terminated

23 enrolled 8 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute